Lv73
3260 积分 2022-03-19 加入
好网站，坚持每天签到，朴素的支持方式
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
2小时前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
2小时前
已完结
Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer
4小时前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
7小时前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
23小时前
已完结
NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
23小时前
已完结
Inflammasome components as new therapeutic targets in inflammatory disease
23小时前
已完结
In silico study to identify novel NEK7 inhibitors from natural source by a combination strategy
23小时前
已完结
Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer
2天前
已完结
Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor
2天前
已完结
皖公网安备34019202002308
